Bicara Therapeutics BCAX 12 months or more
12 months or more at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Bicara Therapeutics's 12 months or more?
- Bicara Therapeutics (BCAX) reported 12 months or more of $0 in Q1 2026.